0001491340-14-000001.txt : 20140313 0001491340-14-000001.hdr.sgml : 20140313 20140313123550 ACCESSION NUMBER: 0001491340-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140313 DATE AS OF CHANGE: 20140313 EFFECTIVENESS DATE: 20140313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exosome Diagnostics, Inc. CENTRAL INDEX KEY: 0001491340 IRS NUMBER: 800191640 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-213510 FILM NUMBER: 14690247 BUSINESS ADDRESS: STREET 1: LASKER BIOMEDICAL RESEARCH BUILDING STREET 2: 3960 BROADWAY, SUITE 540 CITY: NEW YORK STATE: NY ZIP: 10032 BUSINESS PHONE: 646-339-3139 MAIL ADDRESS: STREET 1: LASKER BIOMEDICAL RESEARCH BUILDING STREET 2: 3960 BROADWAY, SUITE 540 CITY: NEW YORK STATE: NY ZIP: 10032 FORMER COMPANY: FORMER CONFORMED NAME: Exosome Theranostics, Inc. DATE OF NAME CHANGE: 20100506 D 1 primary_doc.xml X0707 D LIVE 0001491340 Exosome Diagnostics, Inc. LASKER BIOMEDICAL RESEARCH BUILDING 3960 BROADWAY, SUITE 540 NEW YORK NY NEW YORK 10032 646-339-3139 DELAWARE Exosome Theranostics, Inc. Corporation true James McCullough Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Executive Officer Director Joseph Boystak Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Director Geert-Jan Mulder Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Director Peter Johann Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Director Sara Barrington Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Executive Officer Joseph Slattery Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Director Dhingra Kapil Lasker Biomedical Research Building 3960 Broadway, Suite 540 New York NY NEW YORK 10032 Director Biotechnology Decline to Disclose 06b false 2014-03-03 false true false 0 Leerink Partners LLC 39011 None None 1 Federal Street 37th Floor Boston MA MASSACHUSETTS 02110 CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK false Hudson Capital Advisors BD LLC 132424 None None 100 Wilshire Blvd. Suite 250 Santa Monica CA CALIFORNIA 90401 CT CONNECTICUT NY NEW YORK false 39999985 27092442 12907543 The amount sold shown Item 13 and number of investors shown in Item 14 include $13,849,959 from 5 non-US investors. false 26 896992 0 0 true The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business false Exosome Diagnostics, Inc. /s/James McCullough James McCullough Chief Executive Officer 2014-03-12